Additionally, it was reported that SHG-44 cells resistant to paclitaxel expressed high levels of plasmacytoma variant translocation 1(PVT1) in vitro and the knocking down of this gene improved the chemo-response; the above effects resulted in this long coding RNA being able to track the response to paclitaxel in glioma patients. This evidence concerns the gene PVT1 and glioma.